An increasing number of Americans are embracing gig work as full-time employment opportunities slow down. While gig jobs feel commonplace today, this trend is expected to expand further in the coming years.

The enthusiasm around AI-driven drug discovery is growing as leading pharmaceutical companies, innovative startups, and notable figures like Sam Altman significantly increase their investments.

With AI transitioning from pilot projects to widespread adoption, managers are increasingly tasked with navigating new AI-related challenges and responsibilities in real time.

As AI evolves from trial phases to widespread adoption, managers must quickly adapt by defining their new AI-driven roles and addressing emerging challenges in real time.

Intel has confirmed the completion of Nvidia's $5 billion investment, involving the purchase of 214.8 million shares at $23.28 each. This strategic partnership paves the way for enhanced cooperation between the two companies, focusing on developing an x86-compatible platform to support Nvidia's AI infrastructure advancements.

Eli Lilly made history by becoming the first healthcare company to reach a $1 trillion market capitalization, driven largely by the rapid growth and popularity of its weight-loss drugs.

xAI's latest valuation could surpass $200 billion, more than doubling the previously disclosed $113 billion when it acquired Musk's social media company X.

Nvidia entered the quarter burdened with high expectations tied to the broader market outlook, and it emerged with impressive earnings that may prompt analysts to revise their forecasts upward.

Discover effective AI-driven productivity tips designed to automate routine tasks, optimize your workflow, and help you gain valuable hours in your workweek.

Learn how artificial intelligence can optimize your email experience by automating tasks, prioritizing important messages, and transforming your inbox into an efficient productivity hub.